{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T20:28:21Z","timestamp":1793824101330,"version":"4.6.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:00:00Z","timestamp":1773360000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000},"content-version":"vor","delay-in-days":20,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272624"],"award-info":[{"award-number":["82272624"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272839"],"award-info":[{"award-number":["82272839"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Lenvatinib is a first-line therapeutic option for advanced hepatocellular carcinoma (HCC), while acquired resistance severely limits its clinical efficacy. The precise molecular targets reversing Lenvatinib resistance remain inadequately explored. This study aims to elucidate the role of ubiquitin-specific peptidase 1 (USP1) in mediating resistance and identify potential therapeutic targets to improve treatment outcomes in HCC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Comprehensive analyses employing genetic modulation (USP1 knockdown and overexpression), pharmacological inhibition, and a series of in vitro and in vivo assays were conducted to assess the effects of USP1 on HCC cell sensitivity to Lenvatinib. Mass spectrometry-based proteomics, integrated bioinformatics analysis, and subsequent molecular validation techniques were utilized to systematically identify key USP1 substrates and interacting E3 ubiquitin ligases. Additionally, virtual screening was conducted using the ChemDiv library to identify potential inhibitors, followed by validation of candidate compounds through in vitro and in vivo experiments.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Depletion of USP1 markedly enhanced sensitivity to Lenvatinib in HCC cells, while its overexpression induced resistance. Notably, USP1 knockdown led to obvious chromosome misalignment during metaphase in the presence of Lenvatinib. Mechanistically, Polo-like kinase 1 (PLK1) was identified as a critical substrate stabilized by USP1-mediated deubiquitination, essential for maintaining chromosome alignment and facilitating drug resistance. Additionally, we discovered that the E3 ubiquitin ligase STIP1 homology and U-box-containing protein 1 (STUB1) antagonized with USP1 to regulate PLK1 stability, further modulating resistance of HCC cells. c-Myc was identified as a transcriptional regulator of USP1, establishing a positive feedback loop as USP1\/ PLK1\/ c-Myc axis. Importantly, NTUZLB-001, a novel compound identified via in silico screening, effectively overcame resistance by promoting PLK1 destabilization.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our findings reveal a novel mechanism wherein USP1 promotes Lenvatinib resistance in HCC by regulating chromosome alignment through PLK1 deubiquitination. Targeting the USP1\/PLK1 axis with NTUZLB-001 represents a promising therapeutic strategy to overcome drug resistance and enhance the clinical efficacy of Lenvatinib in HCC treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13046-026-03683-w","type":"journal-article","created":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T23:44:15Z","timestamp":1773359055000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["USP1 driven mitotic dysregulation and PLK1 stabilization confer Lenvatinib resistance in hepatocellular carcinoma"],"prefix":"10.1186","volume":"45","author":[{"given":"Yuwei","family":"Qiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saiyan","family":"Bian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiting","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhangzhi","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengchen","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Banglong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kexin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuyang","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinlong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingbing","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjie","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,13]]},"reference":[{"issue":"1","key":"3683_CR1","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","volume":"7","author":"JM Llovet","year":"2021","unstructured":"Llovet JM, Kelley RK, Villanueva A, Singal AG, Pikarsky E, Roayaie S, et al. Hepatocellular carcinoma. Nat Rev Dis Primers. 2021;7(1):6.","journal-title":"Nat Rev Dis Primers"},{"key":"3683_CR2","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1002\/hep.31306","volume":"73 Suppl 1","author":"RS Finn","year":"2021","unstructured":"Finn RS, Zhu AX. Evolution of Systemic Therapy for Hepatocellular Carcinoma. Hepatology. 2021;73 Suppl 1:150\u20137.","journal-title":"Hepatology"},{"key":"3683_CR3","doi-asserted-by":"publisher","first-page":"1153991","DOI":"10.3389\/fphar.2023.1153991","volume":"14","author":"W Bo","year":"2023","unstructured":"Bo W, Chen Y. Lenvatinib resistance mechanism and potential ways to conquer. Front Pharmacol. 2023;14:1153991.","journal-title":"Front Pharmacol"},{"key":"3683_CR4","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1146\/annurev-biochem-061516-044916","volume":"86","author":"TET Mevissen","year":"2017","unstructured":"Mevissen TET, Komander D. Mechanisms of deubiquitinase specificity and regulation. Annu Rev Biochem. 2017;86:159\u201392.","journal-title":"Annu Rev Biochem"},{"issue":"1","key":"3683_CR5","doi-asserted-by":"publisher","first-page":"7643","DOI":"10.1038\/s41467-022-35244-y","volume":"13","author":"I Erven","year":"2022","unstructured":"Erven I, Abraham E, Hermanns T, Baumann U, Hofmann K. A widely distributed family of eukaryotic and bacterial deubiquitinases related to herpesviral large tegument proteins. Nat Commun. 2022;13(1):7643.","journal-title":"Nat Commun"},{"issue":"19","key":"3683_CR6","doi-asserted-by":"publisher","first-page":"2373","DOI":"10.1038\/onc.2011.443","volume":"31","author":"JM Fraile","year":"2012","unstructured":"Fraile JM, Quesada V, Rodr\u00edguez D, Freije JMP, L\u00f3pez-Ot\u00edn C. Deubiquitinases in cancer: new functions and therapeutic options. Oncogene. 2012;31(19):2373\u201388.","journal-title":"Oncogene"},{"issue":"9","key":"3683_CR7","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1038\/s41388-021-02167-9","volume":"41","author":"H Li","year":"2022","unstructured":"Li H, Roy M, Liang L, Cao W, Hu B, Li Y, et al. Deubiquitylase USP12 induces pro-survival autophagy and bortezomib resistance in multiple myeloma by stabilizing HMGB1. Oncogene. 2022;41(9):1298\u2013308.","journal-title":"Oncogene"},{"issue":"11","key":"3683_CR8","doi-asserted-by":"publisher","first-page":"e2205873","DOI":"10.1002\/advs.202205873","volume":"10","author":"T Guan","year":"2023","unstructured":"Guan T, Li M, Song Y, Chen J, Tang J, Zhang C, et al. Phosphorylation of USP29 by CDK1 Governs TWIST1 stability and oncogenic functions. Adv Sci (Weinh). 2023;10(11):e2205873.","journal-title":"Adv Sci (Weinh)"},{"key":"3683_CR9","doi-asserted-by":"publisher","first-page":"629327","DOI":"10.3389\/fonc.2021.629327","volume":"11","author":"W Ni","year":"2021","unstructured":"Ni W, Bian S, Zhu M, Song Q, Zhang J, Xiao M, et al. Identification and validation of ubiquitin-specific proteases as a novel prognostic signature for hepatocellular carcinoma. Front Oncol. 2021;11:629327.","journal-title":"Front Oncol"},{"key":"3683_CR10","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/1476-4598-12-91","volume":"12","author":"I Garc\u00eda-Santisteban","year":"2013","unstructured":"Garc\u00eda-Santisteban I, Peters GJ, Giovannetti E, Rodr\u00edguez JA. USP1 deubiquitinase: cellular functions, regulatory mechanisms and emerging potential as target in cancer therapy. Mol Cancer. 2013;12:91.","journal-title":"Mol Cancer"},{"issue":"1","key":"3683_CR11","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/s13046-021-02008-3","volume":"40","author":"Y Liao","year":"2021","unstructured":"Liao Y, Shao Z, Liu Y, Xia X, Deng Y, Yu C, et al. USP1-dependent RPS16 protein stability drives growth and metastasis of human hepatocellular carcinoma cells. J Exp Clin Cancer Res. 2021;40(1):201.","journal-title":"J Exp Clin Cancer Res"},{"issue":"4","key":"3683_CR12","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1038\/s41419-023-05777-1","volume":"14","author":"D Liu","year":"2023","unstructured":"Liu D, Li Q, Zang Y, Li X, Li Z, Zhang P, et al. USP1 modulates hepatocellular carcinoma progression via the Hippo\/TAZ axis. Cell Death Dis. 2023;14(4):264.","journal-title":"Cell Death Dis"},{"key":"3683_CR13","doi-asserted-by":"crossref","unstructured":"Kalous J, Aleshkina D. Multiple roles of PLK1 in mitosis and meiosis. Cells. 2023;12(1):187.","DOI":"10.3390\/cells12010187"},{"issue":"14","key":"3683_CR14","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.4161\/cc.10.14.16494","volume":"10","author":"G de C\u00e1rcer","year":"2011","unstructured":"de C\u00e1rcer G, Manning G, Malumbres M. From Plk1 to Plk5: functional evolution of polo-like kinases. Cell Cycle. 2011;10(14):2255\u201362.","journal-title":"Cell Cycle"},{"key":"3683_CR15","doi-asserted-by":"crossref","unstructured":"Houston J, Ohta M, G\u00f3mez-Cavazos JS, Deep A, Corbett KD, Oegema K et al. BUB-1-bound PLK-1 directs CDC-20 kinetochore recruitment to ensure timely embryonic mitoses. Curr Biol. 2023; 33(11):2291\u20139.","DOI":"10.1016\/j.cub.2023.04.021"},{"issue":"4","key":"3683_CR16","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1038\/s41388-019-1049-2","volume":"39","author":"S-B Shin","year":"2020","unstructured":"Shin S-B, Jang H-R, Xu R, Won J-Y, Yim H. Correction: active PLK1-driven metastasis is amplified by TGF-\u03b2 signaling that forms a positive feedback loop in non-small cell lung cancer. Oncogene. 2020;39(4):951.","journal-title":"Oncogene"},{"key":"3683_CR17","doi-asserted-by":"crossref","unstructured":"Lashen AG, Toss MS, Wootton L, Green AR, Mongan NP, Madhusudan S et al. Characteristics and prognostic significance of polo-like kinase-1 (PLK1) expression in breast cancer. Histopathology. 2023;83(3):414\u201325.","DOI":"10.1111\/his.14960"},{"key":"3683_CR18","doi-asserted-by":"crossref","unstructured":"Zhang J, Zhang L, Wang J, Ouyang L, Wang Y. Polo-like Kinase 1 Inhibitors in human cancer therapy: development and therapeutic potential. J Med Chem. 2022;65(15):10133\u201360.","DOI":"10.1021\/acs.jmedchem.2c00614"},{"issue":"4","key":"3683_CR19","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1002\/med.21392","volume":"36","author":"J Van den Bossche","year":"2016","unstructured":"Van den Bossche J, Lardon F, Deschoolmeester V, De Pauw I, Vermorken JB, Specenier P, et al. Spotlight on volasertib: preclinical and clinical evaluation of a promising Plk1 inhibitor. Med Res Rev. 2016;36(4):749\u201386.","journal-title":"Med Res Rev"},{"issue":"8","key":"3683_CR20","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1158\/1078-0432.CCR-22-2206","volume":"29","author":"\u00c1 Guerrero-Zotano","year":"2023","unstructured":"Guerrero-Zotano \u00c1, Belli S, Zielinski C, Gil-Gil M, Fernandez-Serra A, Ruiz-Borrego M, et al. CCNE1 and PLK1 Mediate resistance to Palbociclib in HR+\/HER2- metastatic breast cancer. Clin Cancer Res. 2023;29(8):1557\u201368.","journal-title":"Clin Cancer Res"},{"issue":"23","key":"3683_CR21","doi-asserted-by":"publisher","first-page":"e2100759","DOI":"10.1002\/advs.202100759","volume":"8","author":"Z Yu","year":"2021","unstructured":"Yu Z, Deng P, Chen Y, Liu S, Chen J, Yang Z, et al. Inhibition of the PLK1-Coupled cell cycle machinery overcomes resistance to oxaliplatin in colorectal cancer. Adv Sci (Weinh). 2021;8(23):e2100759.","journal-title":"Adv Sci (Weinh)"},{"key":"3683_CR22","doi-asserted-by":"crossref","unstructured":"Cheng X, Liu Y, Wang J, Chen Y, Robertson AG, Zhang X et al. cSurvival: a web resource for biomarker interactions in cancer outcomes and in cell lines. Brief Bioinform. 2022;23(3):bbac090.","DOI":"10.1093\/bib\/bbac090"},{"issue":"1","key":"3683_CR23","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/s41467-017-00299-9","volume":"8","author":"Y Li","year":"2017","unstructured":"Li Y, Xie P, Lu L, Wang J, Diao L, Liu Z, et al. An integrated bioinformatics platform for investigating the human E3 ubiquitin ligase-substrate interaction network. Nat Commun. 2017;8(1):347.","journal-title":"Nat Commun"},{"issue":"8","key":"3683_CR24","doi-asserted-by":"publisher","first-page":"1950","DOI":"10.1002\/prot.22711","volume":"78","author":"K Lindorff-Larsen","year":"2010","unstructured":"Lindorff-Larsen K, Piana S, Palmo K, Maragakis P, Klepeis JL, Dror RO, et al. Improved side-chain torsion potentials for the Amber ff99SB protein force field. Proteins. 2010;78(8):1950\u20138.","journal-title":"Proteins"},{"issue":"26","key":"3683_CR25","doi-asserted-by":"publisher","first-page":"9004","DOI":"10.1021\/jp901540t","volume":"113","author":"RB Best","year":"2009","unstructured":"Best RB, Hummer G. Optimized molecular dynamics force fields applied to the helix-coil transition of polypeptides. J Phys Chem B. 2009;113(26):9004\u201315.","journal-title":"J Phys Chem B"},{"issue":"3","key":"3683_CR26","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1002\/prot.21123","volume":"65","author":"V Hornak","year":"2006","unstructured":"Hornak V, Abel R, Okur A, Strockbine B, Roitberg A, Simmerling C. Comparison of multiple Amber force fields and development of improved protein backbone parameters. Proteins. 2006;65(3):712\u201325.","journal-title":"Proteins"},{"issue":"9","key":"3683_CR27","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1002\/jcc.20035","volume":"25","author":"J Wang","year":"2004","unstructured":"Wang J, Wolf RM, Caldwell JW, Kollman PA, Case DA. Development and testing of a general amber force field. J Comput Chem. 2004;25(9):1157\u201374.","journal-title":"J Comput Chem"},{"issue":"3","key":"3683_CR28","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1103\/PhysRevA.31.1695","volume":"31","author":"WG Hoover","year":"1985","unstructured":"Hoover WG. Canonical dynamics: equilibrium phase-space distributions. Phys Rev Gen Phys. 1985;31(3):1695\u20137.","journal-title":"Phys Rev Gen Phys"},{"issue":"8","key":"3683_CR29","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1038\/nsmb.1628","volume":"16","author":"SM Yun","year":"2009","unstructured":"Yun SM, Moulaei T, Lim D, Bang JK, Park JE, Shenoy SR, et al. Structural and functional analyses of minimal phosphopeptides targeting the polo-box domain of polo-like kinase 1. Nat Struct Mol Biol. 2009;16(8):876\u201382.","journal-title":"Nat Struct Mol Biol"},{"issue":"12","key":"3683_CR30","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1093\/bioinformatics\/btu097","volume":"30","author":"BG Pierce","year":"2014","unstructured":"Pierce BG, Wiehe K, Hwang H, Kim BH, Vreven T, Weng Z. ZDOCK server: interactive docking prediction of protein-protein complexes and symmetric multimers. Bioinformatics. 2014;30(12):1771\u20133.","journal-title":"Bioinformatics"},{"issue":"12","key":"3683_CR31","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1093\/bioinformatics\/btx068","volume":"33","author":"IH van der Moal","year":"2017","unstructured":"Moal IH, Barradas-Bautista D, Jimenez-Garcia B, Torchala M, van der Velde A, Vreven T, et al. IRaPPA: information retrieval based integration of biophysical models for protein assembly selection. Bioinformatics. 2017;33(12):1806\u201313.","journal-title":"Bioinformatics"},{"key":"3683_CR32","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1758-2946-3-33","volume":"3","author":"NM O\u2019Boyle","year":"2011","unstructured":"O\u2019Boyle NM, Banck M, James CA, Morley C, Vandermeersch T, Hutchison GR. Open Babel: An open chemical toolbox. J Cheminform. 2011;3:33.","journal-title":"J Cheminform"},{"issue":"11","key":"3683_CR33","doi-asserted-by":"publisher","first-page":"3336","DOI":"10.1021\/acs.jctc.2c01145","volume":"19","author":"Y Yu","year":"2023","unstructured":"Yu Y, Cai C, Wang J, Bo Z, Zhu Z, Zheng H. Uni-Dock: GPU-Accelerated docking enables ultralarge virtual screening. J Chem Theory Comput. 2023;19(11):3336\u201345.","journal-title":"J Chem Theory Comput"},{"key":"3683_CR34","doi-asserted-by":"crossref","unstructured":"Yang M, Bo Z, Xu T, Xu B, Wang D, Zheng H. Uni-GBSA: an open-source and web-based automatic workflow to perform MM\/GB(PB)SA calculations for virtual screening. Brief Bioinform. 2023;24(4):bbad218.","DOI":"10.1093\/bib\/bbad218"},{"issue":"10","key":"3683_CR35","doi-asserted-by":"publisher","first-page":"6281","DOI":"10.1021\/acs.jctc.1c00645","volume":"17","author":"MS Valdes-Tresanco","year":"2021","unstructured":"Valdes-Tresanco MS, Valdes-Tresanco ME, Valiente PA, Moreno E. gmx_MMPBSA: a new tool to perform end-state free energy calculations with GROMACS. J Chem Theory Comput. 2021;17(10):6281\u201391.","journal-title":"J Chem Theory Comput"},{"issue":"9","key":"3683_CR36","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1038\/s41418-024-01342-1","volume":"31","author":"S Bian","year":"2024","unstructured":"Bian S, Ni W, Zhou L, Tong Y, Dai C, Zhao X, et al. Ubiquitin-specific protease 1 facilitates hepatocellular carcinoma progression by modulating mitochondrial fission and metabolic reprogramming via cyclin-dependent kinase 5 stabilization. Cell Death Differ. 2024;31(9):1202\u201318.","journal-title":"Cell Death Differ"},{"issue":"4","key":"3683_CR37","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1038\/s41418-021-00899-5","volume":"29","author":"J Zheng","year":"2022","unstructured":"Zheng J, Tan Y, Liu X, Zhang C, Su K, Jiang Y, et al. NAT10 regulates mitotic cell fate by acetylating Eg5 to control bipolar spindle assembly and chromosome segregation. Cell Death Differ. 2022;29(4):846\u201360.","journal-title":"Cell Death Differ"},{"issue":"4","key":"3683_CR38","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/s41594-021-00576-8","volume":"28","author":"ML Rennie","year":"2021","unstructured":"Rennie ML, Arkinson C, Chaugule VK, Toth R, Walden H. Structural basis of FANCD2 deubiquitination by USP1-UAF1. Nat Struct Mol Biol. 2021;28(4):356\u201364.","journal-title":"Nat Struct Mol Biol"},{"issue":"1","key":"3683_CR39","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/s13046-021-02008-3","volume":"40","author":"Y Liao","year":"2021","unstructured":"Liao Y, Shao Z, Liu Y, Xia X, Deng Y, Yu C, et al. USP1-dependent RPS16 protein stability drives growth and metastasis of human hepatocellular carcinoma cells. J experimental Clin cancer research: CR. 2021;40(1):201.","journal-title":"J experimental Clin cancer research: CR"},{"issue":"5","key":"3683_CR40","doi-asserted-by":"publisher","first-page":"eaav3235","DOI":"10.1126\/sciadv.aav3235","volume":"5","author":"M Sonego","year":"2019","unstructured":"Sonego M, Pellarin I, Costa A, Vinciguerra GLR, Coan M, Kraut A, et al. USP1 links platinum resistance to cancer cell dissemination by regulating snail stability. Sci Adv. 2019;5(5):eaav3235.","journal-title":"Sci Adv"},{"issue":"13","key":"3683_CR41","doi-asserted-by":"publisher","first-page":"5949","DOI":"10.7150\/thno.72826","volume":"12","author":"A Tyagi","year":"2022","unstructured":"Tyagi A, Kaushal K, Chandrasekaran AP, Sarodaya N, Das S, Park CH, et al. CRISPR\/Cas9-based genome-wide screening for deubiquitinase subfamily identifies USP1 regulating MAST1-driven cisplatin-resistance in cancer cells. Theranostics. 2022;12(13):5949\u201370.","journal-title":"Theranostics"},{"issue":"17","key":"3683_CR42","doi-asserted-by":"publisher","first-page":"e2109581","DOI":"10.1002\/adma.202109581","volume":"34","author":"MI Arjona","year":"2022","unstructured":"Arjona MI, Duch M, Hern\u00e1ndez-Pinto A, V\u00e1zquez P, Agusil JP, G\u00f3mez-Mart\u00ednez R, et al. Intracellular mechanical drugs induce cell-cycle altering and cell death. Adv Mater. 2022;34(17):e2109581.","journal-title":"Adv Mater"},{"issue":"1","key":"3683_CR43","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1186\/s13046-019-1457-8","volume":"38","author":"Y Peng","year":"2019","unstructured":"Peng Y, Liu Y, Gao Y, Yuan B, Qi X, Fu Y, et al. USP7 is a novel Deubiquitinase sustaining PLK1 protein stability and regulating chromosome alignment in mitosis. J experimental Clin cancer research: CR. 2019;38(1):468.","journal-title":"J experimental Clin cancer research: CR"},{"issue":"12","key":"3683_CR44","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1007\/s00018-017-2457-5","volume":"74","author":"J Liu","year":"2017","unstructured":"Liu J, Zhang C. The equilibrium of ubiquitination and deubiquitination at PLK1 regulates sister chromatid separation. Cell Mol Life Sci. 2017;74(12):2127\u201334.","journal-title":"Cell Mol Life Sci"},{"issue":"4","key":"3683_CR45","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/ncb2695","volume":"15","author":"J Beck","year":"2013","unstructured":"Beck J, Maerki S, Posch M, Metzger T, Persaud A, Scheel H, et al. Ubiquitylation-dependent localization of PLK1 in mitosis. Nat Cell Biol. 2013;15(4):430\u20139.","journal-title":"Nat Cell Biol"},{"issue":"27","key":"3683_CR46","doi-asserted-by":"publisher","first-page":"e2302025","DOI":"10.1002\/advs.202302025","volume":"10","author":"Y Liao","year":"2023","unstructured":"Liao Y, Liu Y, Yu C, Lei Q, Cheng J, Kong W, et al. HSP90\u03b2 Impedes STUB1-Induced ubiquitination of YTHDF2 to drive sorafenib resistance in hepatocellular carcinoma. Adv Sci (Weinh). 2023;10(27):e2302025.","journal-title":"Adv Sci (Weinh)"},{"issue":"4","key":"3683_CR47","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41575-022-00704-9","volume":"20","author":"C Yang","year":"2023","unstructured":"Yang C, Zhang H, Zhang L, Zhu AX, Bernards R, Qin W, et al. Evolving therapeutic landscape of advanced hepatocellular carcinoma. Nat Reviews Gastroenterol Hepatol. 2023;20(4):203\u201322.","journal-title":"Nat Reviews Gastroenterol Hepatol"},{"issue":"16","key":"3683_CR48","doi-asserted-by":"publisher","first-page":"2904","DOI":"10.1200\/JCO.22.02152","volume":"41","author":"V Makker","year":"2023","unstructured":"Makker V, Colombo N, Herr\u00e1ez AC, Monk BJ, Mackay H, Santin AD, et al. Lenvatinib Plus Pembrolizumab in previously treated advanced endometrial cancer: updated efficacy and safety from the randomized phase III study 309\/KEYNOTE-775. J Clin Oncol. 2023;41(16):2904\u201310.","journal-title":"J Clin Oncol"},{"issue":"2","key":"3683_CR49","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1158\/0008-5472.CAN-22-1533","volume":"83","author":"JC Patterson","year":"2023","unstructured":"Patterson JC, Varkaris A, Croucher PJP, Ridinger M, Dalrymple S, Nouri M, et al. Plk1 inhibitors and abiraterone synergistically disrupt mitosis and kill cancer cells of disparate origin independently of androgen receptor signaling. Cancer Res. 2023;83(2):219\u201338.","journal-title":"Cancer Res"}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13046-026-03683-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-026-03683-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-026-03683-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T19:50:39Z","timestamp":1781639439000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13046-026-03683-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,13]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3683"],"URL":"https:\/\/doi.org\/10.1186\/s13046-026-03683-w","relation":{},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,13]]},"assertion":[{"value":"12 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study complies with the Declaration of Helsinki and was approved by the Ethics Committee of the Affiliated Hospital of Nantong University (approval No. 2023-L038; date: 03\/02\/2023), which operates in accordance with the Declaration of Helsinki. Given the retrospective design and use of de-identified data and specimens, the Committee granted a waiver of informed consent. All animal experimental protocols were Approved by the Animal Care and Use Committee of Nantong University (approval No. P20230221-017; date: 02\/21\/2023). The Committee acts in accordance with ICLAS Ethics and Animal Welfare Committee guidelines (ICLAS Governing Board approval: 6 June 2013).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"87"}}